An Interview With Prokarium – Clinical Stage Biotechnology Company About Recently Raised $21 Million Series B Funding
Below is our recent interview with Ted Fjällman, Chief Executive Officer at Prokarium: Q: What is Prokarium? For those who have never heard of it, tell us something more? A: Prokarium is a venture backed clinical stage biotechnology company...